{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T21:49:08Z","timestamp":1768513748968,"version":"3.49.0"},"reference-count":11,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1210\/jc.2019-00524","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T10:06:04Z","timestamp":1552385164000},"page":"3129-3130","source":"Crossref","is-referenced-by-count":2,"title":["Response to Letter to the Editor: \u201cProgesterone Is Important for Transgender Women\u2019s Therapy\u2014Applying Evidence for the Benefits of Progesterone in Ciswomen\u201d"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-0597","authenticated-orcid":false,"given":"Jerilynn C","family":"Prior","sequence":"first","affiliation":[{"name":"Department of Medicine\/Division of Endocrinology, Centre for Menstrual Cycle and Ovulation Research, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"British Columbia Women's Health Research Institute, Vancouver, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"issue":"4","key":"2019061421195216000_bib1","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1210\/jc.2018-01777","article-title":"Progesterone is important for transgender women\u2019s therapy\u2014applying evidence for the benefits of progesterone in ciswomen","volume":"104","author":"Prior","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019061421195216000_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/edrv-11-2-266","article-title":"Progestin regulation of cellular proliferation","volume":"11","author":"Clarke","year":"1990","journal-title":"Endocr Rev"},{"issue":"1","key":"2019061421195216000_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01579291","article-title":"Spironolactone with physiological female gonadal steroids in the presurgical therapy of male to female transexuals: a new observation","volume":"18","author":"Prior","year":"1989","journal-title":"Arch Sex Behav"},{"issue":"5","key":"2019061421195216000_bib4","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/jsm.12487","article-title":"Clinical review: breast development in trans women receiving cross-sex hormones","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"issue":"1","key":"2019061421195216000_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13643-016-0294-5","article-title":"Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis","volume":"5","author":"Asi","year":"2016","journal-title":"Syst Rev"},{"issue":"3","key":"2019061421195216000_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jbmr.3612","article-title":"Bone safety during the first ten years of gender-affirming hormonal treatment in transwomen and transmen","volume":"34","author":"Wiepjes","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2019061421195216000_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.carj.2016.10.006","article-title":"Gender identity and bone densitometry","volume":"68","author":"Hammond","year":"2017","journal-title":"Can Assoc Radiol J"},{"issue":"1","key":"2019061421195216000_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.14200\/jrm.2014.3.0106","article-title":"Progesterone within ovulatory menstrual cycles needed for cardiovascular protection- an evidence-based hypothesis","volume":"3","author":"Prior","year":"2014","journal-title":"J Restor Med"},{"issue":"1","key":"2019061421195216000_bib9","doi-asserted-by":"crossref","first-page":"e84698","DOI":"10.1371\/journal.pone.0084698","article-title":"Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women","volume":"9","author":"Prior","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2019061421195216000_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"2019061421195216000_bib11","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender incongruent persons: an endocrine clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/8\/3129\/28832330\/jc.2019-00524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T21:20:02Z","timestamp":1560547202000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/8\/3129\/5372735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":11,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,3,12]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2019-00524","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,3,12]]}}}